ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,519,334 | -30.5% | 210,921 | -10.0% | 0.02% | -37.8% |
Q2 2023 | $10,816,009 | -34.9% | 234,468 | -43.4% | 0.04% | -37.3% |
Q1 2023 | $16,610,503 | +224245.0% | 414,227 | +159.2% | 0.06% | +118.5% |
Q4 2022 | $7,404 | -99.9% | 159,819 | -15.5% | 0.03% | -10.0% |
Q3 2022 | $7,830,000 | +1169.0% | 189,094 | +1727.0% | 0.03% | +1400.0% |
Q2 2022 | $617,000 | -29.8% | 10,350 | -1.0% | 0.00% | -33.3% |
Q4 2021 | $879,000 | +7.1% | 10,454 | +14.8% | 0.00% | 0.0% |
Q3 2021 | $821,000 | -90.1% | 9,108 | -84.8% | 0.00% | -91.7% |
Q4 2020 | $8,291,000 | – | 59,891 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 75,000 | $4,658,000 | 2.63% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,364,434 | $84,745,000 | 1.21% |
CAPITAL INTERNATIONAL LTD /CA/ | 259,700 | $16,130,000 | 1.07% |
Aureus Asset Management, LLC | 65,670 | $4,079,000 | 0.69% |
Capital International Sarl | 124,320 | $7,722,000 | 0.67% |
CAPITAL GUARDIAN TRUST CO | 512,430 | $31,827,000 | 0.58% |
ROCKEFELLER FINANCIAL SERVICES INC | 408,379 | $25,365,000 | 0.50% |
Rock Springs Capital Management LP | 160,500 | $9,969,000 | 0.50% |
Hood River Capital Management LLC | 112,296 | $6,975,000 | 0.48% |
Capital International, Inc./CA/ | 52,700 | $3,273,000 | 0.47% |